Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05171881 · ClinicalTrials.gov registry record · Phase 2
Brain Oxygenation-II
A Phase 2 study of Cerebral Hypoxia, sponsored by Valerie Chock, M.D., M.S. Epi.
- Active
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 5
- Study locations
NCT05171881 is a Phase 2 study of Cerebral Hypoxia that is active but no longer recruiting, run by Valerie Chock, M.D., M.S. Epi. The registered enrollment target is 100 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT05171881, a Phase 2 study of Cerebral Hypoxia, is active but no longer recruiting, sponsored by Valerie Chock, M.D., M.S. Epi.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
The Brain Oxygenation-II study (BOx-II) is a phase-II, multicenter, single-arm clinical trial evaluating interventions based on near-infrared spectroscopy (NIRS) monitoring of cerebral oxygen saturation in extremely premature infants. Enrolled infants will follow a treatment guideline to maintain cerebral oxygen saturation in a target range within the first 72 hours of life. The primary outcomes will include interventions used to maintain cerebral saturation in target range, rates of cerebral hypoxia and systemic hypoxia, and a composite of death or severe brain injury detected on term-equivalent magnetic resonance imaging.
Conditions Studied
Interventions
- OTHER Intervention for cerebral hypoxia
Study Locations (5)
California
- Loma Linda University - Loma Linda
- Stanford University - Palo Alto
Missouri
- Washington University in Saint Louis - St Louis
Texas
- University of Texas- Southwestern Medical Center - Dallas
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-04-07 |
| Est. Completion | 2025-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05171881
The ClinicalTrials.gov registry entry for NCT05171881 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Valerie Chock, M.D., M.S. Epi, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cerebral Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Intervention for cerebral hypoxia is the first listed.
NCT05171881 reports 5 study locations spanning 4 distinct geographic areas - top geographies include California, Missouri, Texas.
Frequently Asked Questions
What is clinical trial NCT05171881 about?
NCT05171881 is a clinical study titled "Brain Oxygenation-II". The Brain Oxygenation-II study (BOx-II) is a phase-II, multicenter, single-arm clinical trial evaluating interventions based on near-infrared spectroscopy (NIRS) monitoring of cerebral oxygen saturation in extremely premature infants. Enrolled infants will follow a treatment guideline to maintain ce...
What is the current status of trial NCT05171881?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2022-04-07. Estimated completion is 2025-04.
What conditions does trial NCT05171881 study?
This clinical trial studies the following conditions: Cerebral Hypoxia.
What interventions are being tested in trial NCT05171881?
The interventions under investigation include: Intervention for cerebral hypoxia (OTHER).
Who is sponsoring clinical trial NCT05171881?
This trial is sponsored by Valerie Chock, M.D., M.S. Epi, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05171881 being conducted?
This trial has 5 study locations across California, Missouri, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebral Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.